China Nootropics Market Size & Outlook, 2021-2030
China nootropics market, 2018-2030 (US$M)
Related Markets
China nootropics market highlights
- The China nootropics market generated a revenue of USD 305.0 million in 2021 and is expected to reach USD 1,069.1 million by 2030.
- The China market is expected to grow at a CAGR of 15% from 2022 to 2030.
- In terms of segment, capsules/tablets was the largest revenue generating form in 2021.
- Drinks is the most lucrative form segment registering the fastest growth during the forecast period.
Nootropics market data book summary
| Market revenue in 2021 | USD 305.0 million |
| Market revenue in 2030 | USD 1,069.1 million |
| Growth rate | 15% (CAGR from 2021 to 2030) |
| Largest segment | Capsules/tablets |
| Fastest growing segment | Drinks |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Capsules/Tablets, Powder, Drinks |
| Key market players worldwide | Reckitt Benckiser Group PLC, Mental Mojo, Noocube, Mind Lab, truBrain, Nooflux, Zhou Nutrition, Kimera Koffee |
Other key industry trends
- In terms of revenue, China accounted for 9.2% of the global nootropics market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China nootropics market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 932.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nootropics Market Scope
Nootropics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China nootropics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nootropics market will help companies and investors design strategic landscapes.
Capsules/tablets was the largest segment with a revenue share of 44.79% in 2021. Horizon Databook has segmented the China nootropics market based on capsules/tablets, powder, drinks covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of the nootropics market in China is significantly fueled by the country's position as a major global hub for these cognitive enhancers. China stands as the largest nootropic drug dispensary in the world, with a substantial portion of the world's supply of Piracetam originating from Chinese manufacturers.
China maintains exceptionally high standards of quality control for nootropics and various other drugs, ensuring the production of safe and reliable products. Another driving factor behind the expansion of the Chinese nootropics market is the accessibility for its citizens.
Reasons to subscribe to China nootropics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China nootropics market databook
-
Our clientele includes a mix of nootropics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China nootropics market , including forecasts for subscribers. This country databook contains high-level insights into China nootropics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China nootropics market size, by form, 2018-2030 (US$M)
China Nootropics Market Outlook Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
